COPD Trial, Recruiting NCT05685628 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT05685628
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People over 18 years old who have a wound with an unpleasant smell that causes noticeable discomfort (rated more than 4 out of 10 by the patient)
  • People whose wound is expected to take more than 14 days to heal, based on a doctor's assessment
  • People who are covered by the French social security system (excluding AME — a specific state medical assistance scheme)
  • People who have been informed about the study and have signed a consent form to participate (a legal guardian's signature is also required if applicable)

Who may not be able to join:

  • People who have had a charcoal or cinnamon-based dressing applied to their wound in the last 48 hours
  • People who have a pressure ulcer (bedsore) at stage 1 or 2
  • People who have been taking metronidazole or any antibiotic/antimicrobial treatment for fewer than 3 days
  • People who are unable to communicate how they are feeling
  • People who have no sense of smell
  • People who are allergic to cinnamon
  • People who are in prison or under legal guardianship
  • People who would not be able to attend the required follow-up appointments due to geographical, social, psychological, or cognitive reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Isabelle FROMANTIN, IDE, Institut Curie

Phone: 01 44 32 42 34

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 October 2023
Est. completion
19 April 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Wound-Qol

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov